GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BRSE:001102657 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Dec 24	BuyCHF 22,172	Jonathan Symonds	Individual	1,500	CHF 14.78
20 Dec 24	BuyCHF 8,095	Wendy Mira Becker	Individual	546	CHF 14.83
30 Oct 24	BuyCHF 112,218	Jonathan Symonds	Individual	7,150	CHF 15.69
20 Jun 24	BuyCHF 36,457	Jonathan Symonds	Individual	2,000	CHF 18.23
20 Jun 24	BuyCHF 8,125	Wendy Mira Becker	Individual	446	CHF 18.22
01 Feb 24	BuyCHF 59,967	Jonathan Symonds	Individual	3,500	CHF 17.13
01 Feb 24	BuyCHF 334,278	Julie Brown	Individual	19,360	CHF 17.27

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 001102657?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	2,647,199	0.0654%
Individual Insiders	3,092,214	0.0764%
State or Government	6,645,071	0.164%
Private Companies	22,466,109	0.555%
Employee Share Scheme	76,411,087	1.89%
General Public	587,250,557	14.5%
Institutions	3,350,275,608	82.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.08%	Dodge & Cox	367,520,306	CHF 7.4b	-1.52%	4.05%
6.55%	BlackRock, Inc.	265,087,814	CHF 5.3b	0%	0.13%
4.1%	The Vanguard Group, Inc.	165,964,425	CHF 3.3b	2.97%	0.08%
3.8%	Capital Research and Management Company	153,937,041	CHF 3.1b	1.84%	0.2%
2.3%	State Street Global Advisors, Inc.	92,968,446	CHF 1.9b	-2.22%	0.1%
2.28%	Norges Bank Investment Management	92,120,348	CHF 1.9b	-1.62%	0.24%
2.02%	Legal & General Investment Management Limited	81,974,649	CHF 1.7b	0%	0.65%
1.89%	GlaxoSmithKline Employee Trust	76,411,087	CHF 1.5b	42.4%	no data
1.88%	UBS Asset Management	75,963,866	CHF 1.5b	0.12%	0.28%
1.72%	Schroder Investment Management Limited	69,653,800	CHF 1.4b	-3.03%	1.08%
1.6%	HSBC Global Asset Management (UK) Limited	64,952,924	CHF 1.3b	-13.4%	1.05%
1.48%	Columbia Management Investment Advisers, LLC	60,059,518	CHF 1.2b	1.27%	0.34%
1.15%	FMR LLC	46,515,279	CHF 937.4m	3.42%	0.08%
1.11%	Silchester International Investors LLP	45,026,830	CHF 907.4m	-7.35%	4.45%
0.94%	Mondrian Investment Partners Limited	38,067,196	CHF 767.1m	-10.6%	5.36%
0.88%	Franklin Resources, Inc.	35,677,125	CHF 719.0m	-12.8%	0.29%
0.81%	Fisher Asset Management, LLC	32,750,812	CHF 660.0m	0%	0.46%
0.81%	Aviva Investors Global Services Limited	32,593,763	CHF 656.8m	0.93%	1.36%
0.75%	Ignis Investment Services Limited	30,207,498	CHF 608.7m	-4.68%	2.12%
0.74%	M&G Investment Management Limited	29,946,326	CHF 603.5m	-5.33%	1.23%
0.7%	Northern Trust Global Investments	28,455,940	CHF 573.4m	-5.13%	0.11%
0.68%	J.P. Morgan Asset Management, Inc.	27,550,851	CHF 555.2m	-3.98%	0.1%
0.68%	Societe Generale Group, Banking Investments	27,447,166	CHF 553.1m	61.4%	4.45%
0.66%	BNY Mellon Asset Management	26,577,867	CHF 535.6m	-0.71%	0.12%
0.62%	T. Rowe Price Group, Inc.	25,083,804	CHF 505.5m	0%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/07/24 06:20
End of Day Share Price	2022/07/07 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GSK plc is covered by 64 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kamla Singh	AlphaValue
John Eade	Argus Research Company
Odile Rundquist	Baader Helvea Equity Research